Meeting with HALMED representatives

The main topic of the meeting was AmCham’s position paper “Recommendations for improving the medicinal product pricing process“.

The current Draft Act on Changes to the Act on Medicinal Products foresees the establishment of a new medicinal product pricing system pursuant to which HALMED would establish the highest permitted price of a medicinal product at which a marketing authorization holder could sell the medicinal product on the Croatian market, which is a task currently performed by the Croatian health insurance fund. In the light of these changes, AmCham has issued the position paper, providing clear recommendations for improving the efficiency of the pricing system.

AmCham and HALMED representatives discussed the position paper and AmCham’s recommendations as well as opportunities for cooperation.